Implication of Oncogenic Signaling Pathways as a Treatment Strategy for Neurodegenerative Disorders - Contemporary Approaches

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|10|2|175-183

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.2, 2011-03, pp. : 175-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antioxidants as treatment for neurodegenerative disorders

By Moosmann Bernd   Behl Christian  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 10, 2002-10 ,pp. : 1407-1435

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders

By Castro A.   Martinez A.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 10, 2000-10 ,pp. : 1519-1527

Informa Healthcare

Access to resources Recommend Favorite

Oncogenic Signaling Pathways Activated by RON Receptor Tyrosine Kinase

By  

Current Cancer Drug Targets, Vol. 3, Iss. 1, 2003-02 ,pp. : 31-40

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges and Advances in Gene Therapy Approaches for Neurodegenerative Disorders

By  

Current Gene Therapy, Vol. 17, Iss. 3, 2017-12 ,pp. : 187-193

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of autism spectrum disorders: neurotransmitter signaling pathways involved in motivation and reward as therapeutic targets

By Walker Michael A  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 949-967

Informa Healthcare

Access to resources Recommend Favorite